NuVision Pharmacy, Inc. recalls Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Recalled February 5, 2014 · FDA recall D-1052-2014 · NuVision Pharmacy
Hazard
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection. · FDA Class I
Units
122 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
Product
Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Manufacturer(s)
NuVision Pharmacy, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →